Satigrel (E5510) is a potent inhibitor of platelet aggregation. Satigrel inhibits collagen- and arachidonic acid-induced platelet aggregation through preventing thromboxane A2 synthesis by selective inhibition of the target enzyme, PGHS1, which exists in platelets. Satigrel inhibits PGHS1 (IC50: 0.081 µM) and PGHS2 (IC50: 5.9 µM). Satigrel is against Type III PDE, Type V and Type II (IC50: 15.7 µM, 39.8 µM and 62.4 µM, respectively)[1].
Molekulargewicht:
337.37
Reinheit:
99.85
CAS Nummer:
[111753-73-2]
Formel:
C20H19NO4
Target-Kategorie:
Prostaglandin Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
